Akili (AKLI) stock soared over 100% today: All you need to know

August 22, 2022 08:13 AM PDT | By Rupam Roy

Akili (AKLI) stock soared over 100% today: All you need to know — Image source: © Demidovichphotostock | Megapixl.com

SPAC details:

The digital medicine firm, Akili said last Friday, August 19, that it had completed its business merger with the publicly traded special purpose acquisition company, Social Capital Suvretta Holdings Corp. I.

According to the release by the firm, the newly formed entity, Akili, Inc. was supposed to start trading on the Nasdaq Capital on August 22. The ticker symbol of the newly formed firm is AKLI.

The SPAC merger provided gross proceeds of over US$ 163 million from the transaction, before subtracting transaction and other advisory expenses and fees.

The firm said that it expects the raised amount along with cash on hand would be adequate for funding its business operations for at least 24 months, excluding any revenue contributions from EndeavorRx.

Meanwhile, the gross proceeds from the merger would be used in funding the commercial launch of EndeavorRx. which the company claims to be an FDA-approved and a certified prescription digital therapeutic for children. Notably, the US Food and Drug Administration (FDA) approved the treatment in June 2020.

In addition, it would also provide support in advancing Akili's late-stage pipeline product candidates that are focused on treating neuropsychiatric diseases like autism spectrum disorder (ASD), major depressive disorder (MDD), etc.

According to the company's official release, the shareholders of the firm approved the merger at a general meeting on Thursday, August 18.

Akili, Inc. (AKLI) SPAC merger details Source: ©Kalkine Media®; © Canva Creative Studio via Canva.com

Bottom line:

The stock soared over 100 per cent at market open. However, at 10:51 ET, it was up over 43 per cent to US$ 20.14.

Investors should closely evaluate the company's operating segments and other factors before spending on the stocks. Several small-time investors sometimes circle a newly debuted firm, sending its shares up. But that momentum tends to stay for the short term.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.